Clinical Trial Update: Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating intra-articular resiniferatoxin for moderate to severe knee osteoarthritis pain; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Knee Pain Chronic
• Osteoarthritis Knee

Drugs mentioned

• Resiniferatoxin (resiniferatoxin)

Snippet

Sponsor: Sorrento Therapeutics, Inc. | Conditions: Osteoarthritis, Knee, Knee Osteoarthritis | Phase 2 | Status: UNKNOWN